Intradermal COVID-19 Vaccination in the Immunocompromised

NCT05736913 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: ID BNT162b2 vaccine
BIOLOGICAL: IM BNT162b2 vaccine

Sponsor

The University of Hong Kong